Fidelity Investments’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $177K | Sell |
194,890
-9,216
| -5% | -$8.36K | ﹤0.01% | 3356 |
|
2025
Q1 | $92.2K | Buy |
204,106
+3,201
| +2% | +$1.45K | ﹤0.01% | 3589 |
|
2024
Q4 | $101K | Buy |
200,905
+194,495
| +3,034% | +$97.7K | ﹤0.01% | 3541 |
|
2024
Q3 | $5.8K | Buy |
6,410
+4,537
| +242% | +$4.11K | ﹤0.01% | 4584 |
|
2024
Q2 | $1.87K | Sell |
1,873
-228
| -11% | -$227 | ﹤0.01% | 4729 |
|
2024
Q1 | $3.11K | Buy |
2,101
+751
| +56% | +$1.11K | ﹤0.01% | 4611 |
|
2023
Q4 | $1.47K | Sell |
1,350
-94
| -7% | -$102 | ﹤0.01% | 4701 |
|
2023
Q3 | $1.7K | Sell |
1,444
-649
| -31% | -$766 | ﹤0.01% | 4576 |
|
2023
Q2 | $2.95K | Buy |
2,093
+1,249
| +148% | +$1.76K | ﹤0.01% | 4503 |
|
2023
Q1 | $1.27K | Buy |
844
+62
| +8% | +$93 | ﹤0.01% | 4708 |
|
2022
Q4 | $915 | Sell |
782
-236
| -23% | -$276 | ﹤0.01% | 4669 |
|
2022
Q3 | $1K | Sell |
1,018
-4,408
| -81% | -$4.33K | ﹤0.01% | 4697 |
|
2022
Q2 | $9K | Buy |
5,426
+3,744
| +223% | +$6.21K | ﹤0.01% | 4143 |
|
2022
Q1 | $2K | Buy |
1,682
+1,680
| +84,000% | +$2K | ﹤0.01% | 4676 |
|
2021
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 4696 |
|
2021
Q3 | $0 | Sell |
2
-3
| -60% | – | ﹤0.01% | 4734 |
|
2021
Q2 | $0 | Buy |
+5
| New | – | ﹤0.01% | 4604 |
|
2020
Q1 | – | Sell |
-500
| Closed | – | – | 3996 |
|
2019
Q4 | $0 | Buy |
+500
| New | – | ﹤0.01% | 4065 |
|
2019
Q3 | – | Sell |
-493
| Closed | -$1K | – | 4044 |
|
2019
Q2 | $1K | Buy |
493
+473
| +2,365% | +$959 | ﹤0.01% | 3614 |
|
2019
Q1 | $0 | Buy |
+20
| New | – | ﹤0.01% | 3950 |
|
2014
Q1 | – | Sell |
-759,946
| Closed | -$2.21M | – | 2687 |
|
2013
Q4 | $2.21M | Sell |
759,946
-1,038,480
| -58% | -$3.02M | ﹤0.01% | 2333 |
|
2013
Q3 | $5.52M | Sell |
1,798,426
-82,270
| -4% | -$252K | ﹤0.01% | 2131 |
|
2013
Q2 | $6.01M | Buy |
+1,880,696
| New | +$6.01M | ﹤0.01% | 2086 |
|